Nancy Miller-Rich - Nov 9, 2021 Form 4 Insider Report for Kadmon Holdings, Inc. (KDMN)

Role
Director
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
Stock symbol
KDMN
Transactions as of
Nov 9, 2021
Transactions value $
-$767,912
Form type
4
Date filed
11/9/2021, 04:38 PM
Previous filing
Jun 10, 2021
Next filing
May 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDMN Stock Option (right to buy) Disposed to Issuer -$194K -36.4K -100% $5.33 0 Nov 9, 2021 Common Stock, par value $0.001 36.4K $4.17 Direct F1, F2
transaction KDMN Stock Option (right to buy) Disposed to Issuer -$574K -97K -100% $5.92 0 Nov 9, 2021 Common Stock, par value $0.001 97K $3.58 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Nancy Miller-Rich is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 In connection with the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option.
F2 Represents the payment per share of Common Stock received in exchange for the cancellation of each Option.